Daniel Mikol MD, PhD

Observer
DISC Type : ci

Vice President Neuroscience Development at AbbVie

United States

Overview

Daniel Mikol is the Vice President of Neuroscience Development at AbbVie, leveraging his extensive experience in all phases of clinical development. A graduate of The University of Chicago Pritzker School of Medicine, he has a track record of successful drug approvals, including leading development for major therapies at Amgen and Biogen.

He previously served as Chief Medical Officer at NervGen Pharma, overseeing a Phase 1 trial for a molecule targeting spinal cord injury, and as Therapeutic Area Head for Neuroscience at Amgen.

He led the global clinical development for Aimovig (Erenumab), a transformative CGRP-inhibitor drug for migraine prevention, during his time at Amgen.

Personality Overview

Example Seeker

Curious

Value Driven

They often ask many questions and rely heavily on information and documentation.  They are generally strong communicators and are not easy to convince. They can sound friendly and charming but can quickly change gears to become inquisitive and probing.

Topics They Care About

Neuroscience Drug Development
His entire career at companies like AbbVie, Amgen, and Biogen has focused on bringing new neuroscience therapies through clinical development to regulatory approval.
Migraine Therapeutics
As the Global Development Lead for Erenumab/Aimovig at Amgen, he was instrumental in the creation of a major new class of migraine treatments.
Spinal Cord Injury
As former CMO of NervGen Pharma, he led the clinical strategy for a promising molecule with a lead indication in treating spinal cord injuries.

Media Appearances

Daniel has no verified media appearances

Work History

6-2025
Vice President Neuroscience Development at AbbVie
5-2021 - 6-2025
Chief Medical Officer at NervGen Pharma Corp.
9-2015 - 5-2021
Executive Medical Director Global Development at Amgen
7-2012 - 9-2015
Senior Medical Director, Global MS Clinical Development at Biogen
1-2012 - 6-2012
Principal Medical Scientific Expert at Novartis Consumer Health

Education

1993 - 1996
Neurology residency from University of California, San Francisco
1984 - 1993
MD (and internship) from The University of Chicago Pritzker School of Medicine

More Information

Social Presence :

Prographics :

Exp : 29 Location : United States Job Level : Senior Designation : Vice President Neuroscience Development at AbbVie
URL has been copied!

Insights For Selling To Daniel

During A Call Or A Meeting

DO's

  • Share testimonials from known people and give multiple examples of product value
  • Ask them questions to understand their needs better while staying affable
  • Use phrases like ‘clear proof that’, ‘data shows’ etc.

DONT's

  • Don’t brush off any concerns, take all questions seriously
  • Don’t be too objective but make sure to pad your storytelling with data points
  • Avoid making offhand commitments

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Daniel is

  • Clear proof of product value matters to them, followed by others' testimonials and rapport.
  • Will you ever get a clear answer from Daniel

  • They are practical yet friendly, don’t expect a clear no very often.

Insights For Deal Planning

    How fast (or slow) will Daniel move?

  • They like to analyze well and can take their time to reach any decisions.
  • Can Daniel take some risk or not?

  • They systematically evaluate all decisions and are unlikely to take many risks.

You And Daniel

Personality Compatibility


Other AbbVie Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.